Press releases
- Roche receives FDA clearance on its digital pathology solution for diagnostic use
- Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
- Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
Key statistics
On Tuesday, Chugai Pharmaceutical Co Ltd (4519N:MEX) closed at 528.81, 0.00% below its 52-week high of 528.81, set on May 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 528.81 |
Low | 528.81 |
Bid | -- |
Offer | -- |
Previous close | 528.81 |
Average volume | -- |
---|---|
Shares outstanding | 1.68bn |
Free float | 673.12m |
P/E (TTM) | 29.17 |
Market cap | 9.72tn JPY |
EPS (TTM) | 198.34 JPY |
Annual div (ADY) | 9.59 MXN |
---|---|
Annual div yield (ADY) | 1.81% |
Div ex-date | Dec 28 2023 |
Div pay-date | Mar 29 2024 |
Data delayed at least 20 minutes, as of May 14 2024 12:30 BST.
More ▼